Healthcare Global Enterprises Share Price
Sector: Healthcare Facilities
You have to be logged in to add this to Watchlist.
Login or Register
467.35 -1.05 (-0.22%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
458.75
Today’s High
471.4
52 Week Low
310.1
52 Week High
506.6
468.30 -0.20 (-0.04%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
457
Today’s High
470.5
52 Week Low
314
52 Week High
519.5
Key Metrics
- Market Cap (In Cr) 6530.27
- Beta 0.57
- Div. Yield (%) 0
- P/B 7.9
- TTM P/E 102.26
- Peg Ratio -
- Sector P/E 30.15
- D/E 1.81
- Open Price 459.15
- Prev Close 468.4
Healthcare Global Enterprises Analysis
Price Analysis
-
1 Week0.2%
-
3 Months20.76%
-
6 Month30.5%
-
YTD28.18%
-
1 Year29.38%
Risk Meter
- 28% Low risk
- 28% Moderate risk
- 28% Balanced Risk
- 28% High risk
- 28% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 1
- 1
- 1
- 1
- Buy
- 4
- 4
- 4
- 5
- Hold
- 0
- 0
- 0
- 0
- Sell
- 0
- 0
- 0
- 0
- Strong Sell
- 0
- 0
- 0
- 0
- Total
- 5
- 5
- 5
- 6
Healthcare Global Enterprises News
Equitas Small Finance Bank, RBL Bank & others hit 52 week low today ;Check the full list here?
3 min read . 08 Oct 2024Reliance Communications, The Anup Engineering & others hit 52 week high today ; Do you own any?
4 min read . 08 Oct 2024Federal Bank to SBI Cards—SMC Global lists four stocks to bet on this week
4 min read . 10 Sep 2024Healthcare Global Enterprises Q1 Results Live: Profit Rise by 58.74% YoY
1 min read . 10 Aug 2024Healthcare Global Enterprises Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 1907.87
- Selling/ General/ Admin Expenses Total
- 308.24
- Depreciation/ Amortization
- 174.36
- Other Operating Expenses Total
- 385.3
- Total Operating Expense
- 1752.99
- Operating Income
- 154.88
- Net Income Before Taxes
- 67.72
- Net Income
- 48.14
- Diluted Normalized EPS
- 3.26
- Period
- 2024
- Total Assets
- 2707.5
- Total Liabilities
- 1881.72
- Total Equity
- 825.78
- Tangible Book Valueper Share Common Eq
- 41.14
- Period
- 2024
- Cashfrom Operating Activities
- 284.58
- Cashfrom Investing Activities
- -225.73
- Cashfrom Financing Activities
- -64.02
- Net Changein Cash
- -5.17
- Period
- 2023
- Total Revenue
- 1691.41
- Selling/ General/ Admin Expenses Total
- 605.86
- Depreciation/ Amortization
- 163.47
- Other Operating Expenses Total
- 8.4
- Total Operating Expense
- 1557.52
- Operating Income
- 133.89
- Net Income Before Taxes
- 44.88
- Net Income
- 29.35
- Diluted Normalized EPS
- 2.14
- Period
- 2023
- Total Assets
- 2316.02
- Total Liabilities
- 1455.5
- Total Equity
- 860.52
- Tangible Book Valueper Share Common Eq
- 47.49
- Period
- 2023
- Cashfrom Operating Activities
- 251.59
- Cashfrom Investing Activities
- -133.03
- Cashfrom Financing Activities
- -140.07
- Net Changein Cash
- -21.51
- Period
- 2022
- Total Revenue
- 1394.78
- Selling/ General/ Admin Expenses Total
- 498.86
- Depreciation/ Amortization
- 158.28
- Other Operating Expenses Total
- 5.64
- Total Operating Expense
- 1222.84
- Operating Income
- 171.93
- Net Income Before Taxes
- 87.77
- Net Income
- 53.73
- Diluted Normalized EPS
- -0.54
- Period
- 2022
- Total Assets
- 2219.52
- Total Liabilities
- 1349.24
- Total Equity
- 870.29
- Tangible Book Valueper Share Common Eq
- 47.42
- Period
- 2022
- Cashfrom Operating Activities
- 220.12
- Cashfrom Investing Activities
- 124.59
- Cashfrom Financing Activities
- -154.88
- Net Changein Cash
- 189.82
- Period
- 2021
- Total Revenue
- 1009.19
- Selling/ General/ Admin Expenses Total
- 415.83
- Depreciation/ Amortization
- 159.22
- Other Operating Expenses Total
- 4.86
- Total Operating Expense
- 1139.47
- Operating Income
- -130.28
- Net Income Before Taxes
- -228.66
- Net Income
- -193.46
- Diluted Normalized EPS
- -11.68
- Period
- 2021
- Total Assets
- 2035.61
- Total Liabilities
- 1338.44
- Total Equity
- 697.18
- Tangible Book Valueper Share Common Eq
- 46.22
- Period
- 2021
- Cashfrom Operating Activities
- 120.52
- Cashfrom Investing Activities
- -171.1
- Cashfrom Financing Activities
- 112.24
- Net Changein Cash
- 61.66
- Period
- 2020
- Total Revenue
- 1092.34
- Selling/ General/ Admin Expenses Total
- 428.7
- Depreciation/ Amortization
- 148.44
- Other Operating Expenses Total
- 4.98
- Total Operating Expense
- 1071.9
- Operating Income
- 20.44
- Net Income Before Taxes
- -119.26
- Net Income
- -106.7
- Diluted Normalized EPS
- -12.05
- Period
- 2020
- Total Assets
- 2253.17
- Total Liabilities
- 1871.92
- Total Equity
- 381.26
- Tangible Book Valueper Share Common Eq
- 27.05
- Period
- 2020
- Cashfrom Operating Activities
- 130.14
- Cashfrom Investing Activities
- -101.38
- Cashfrom Financing Activities
- -58.42
- Net Changein Cash
- -29.67
- Period
- 2019
- Total Revenue
- 976.03
- Selling/ General/ Admin Expenses Total
- 414.67
- Depreciation/ Amortization
- 85.09
- Other Operating Expenses Total
- 5.65
- Total Operating Expense
- 938.48
- Operating Income
- 37.54
- Net Income Before Taxes
- -33.38
- Net Income
- -24.8
- Diluted Normalized EPS
- -2.81
- Period
- 2019
- Total Assets
- 1653.54
- Total Liabilities
- 1176.9
- Total Equity
- 476.65
- Tangible Book Valueper Share Common Eq
- 40.72
- Period
- 2019
- Cashfrom Operating Activities
- 98.5
- Cashfrom Investing Activities
- -238.2
- Cashfrom Financing Activities
- 83.51
- Net Changein Cash
- -56.18
- Period
- 2018
- Total Revenue
- 830.69
- Selling/ General/ Admin Expenses Total
- 340.97
- Depreciation/ Amortization
- 71.46
- Other Operating Expenses Total
- 5.65
- Total Operating Expense
- 772.52
- Operating Income
- 58.17
- Net Income Before Taxes
- 27.18
- Net Income
- 20.52
- Diluted Normalized EPS
- 1.61
- Period
- 2018
- Total Assets
- 1443.66
- Total Liabilities
- 928.56
- Total Equity
- 515.1
- Tangible Book Valueper Share Common Eq
- 46.02
- Period
- 2018
- Cashfrom Operating Activities
- 96.39
- Cashfrom Investing Activities
- -281.7
- Cashfrom Financing Activities
- 161.29
- Net Changein Cash
- -24.02
- Period
- 2024-09-30
- Total Revenue
- 552.47
- Selling/ General/ Admin Expenses Total
- 85.27
- Depreciation/ Amortization
- 49.74
- Other Operating Expenses Total
- 103.88
- Total Operating Expense
- 501.01
- Operating Income
- 51.46
- Net Income Before Taxes
- 27.65
- Net Income
- 17.99
- Diluted Normalized EPS
- 1.28
- Period
- 2024-09-30
- Total Assets
- 3067.08
- Total Liabilities
- 2205.29
- Total Equity
- 861.79
- Tangible Book Valueper Share Common Eq
- 43.76
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 125.88
- Cashfrom Investing Activities
- -109.21
- Cashfrom Financing Activities
- -44.92
- Net Changein Cash
- -28.25
- Period
- 2024-06-30
- Total Revenue
- 524.69
- Selling/ General/ Admin Expenses Total
- 85.16
- Depreciation/ Amortization
- 47.01
- Other Operating Expenses Total
- 104.23
- Total Operating Expense
- 481.68
- Operating Income
- 43.01
- Net Income Before Taxes
- 18.99
- Net Income
- 12.08
- Diluted Normalized EPS
- 0.86
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 493.25
- Selling/ General/ Admin Expenses Total
- 76.85
- Depreciation/ Amortization
- 45.98
- Other Operating Expenses Total
- 97.41
- Total Operating Expense
- 444.68
- Operating Income
- 48.57
- Net Income Before Taxes
- 28.22
- Net Income
- 21.26
- Diluted Normalized EPS
- 1.28
- Period
- 2024-03-31
- Total Assets
- 2707.5
- Total Liabilities
- 1881.72
- Total Equity
- 825.78
- Tangible Book Valueper Share Common Eq
- 41.14
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 284.58
- Cashfrom Investing Activities
- -225.73
- Cashfrom Financing Activities
- -64.02
- Net Changein Cash
- -5.17
- Period
- 2023-12-31
- Total Revenue
- 468.95
- Selling/ General/ Admin Expenses Total
- 77.33
- Depreciation/ Amortization
- 44.16
- Other Operating Expenses Total
- 95.7
- Total Operating Expense
- 435.41
- Operating Income
- 33.54
- Net Income Before Taxes
- 11.06
- Net Income
- 5.7
- Diluted Normalized EPS
- 0.41
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 485.96
- Selling/ General/ Admin Expenses Total
- 77.16
- Depreciation/ Amortization
- 43.21
- Other Operating Expenses Total
- 98.01
- Total Operating Expense
- 445.52
- Operating Income
- 40.44
- Net Income Before Taxes
- 17.92
- Net Income
- 13.57
- Diluted Normalized EPS
- 0.97
- Period
- 2023-09-30
- Total Assets
- 2418.89
- Total Liabilities
- 1561.12
- Total Equity
- 857.77
- Tangible Book Valueper Share Common Eq
- 46.32
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 63.69
- Cashfrom Investing Activities
- -63.36
- Cashfrom Financing Activities
- -57.37
- Net Changein Cash
- -57.04
- Period
- 2023-06-30
- Total Revenue
- 459.71
- Selling/ General/ Admin Expenses Total
- 76.9
- Depreciation/ Amortization
- 41.01
- Other Operating Expenses Total
- 94.18
- Total Operating Expense
- 427.38
- Operating Income
- 32.33
- Net Income Before Taxes
- 10.52
- Net Income
- 7.61
- Diluted Normalized EPS
- 0.54
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 440.98
- Selling/ General/ Admin Expenses Total
- 68.86
- Depreciation/ Amortization
- 42.2
- Other Operating Expenses Total
- 88.84
- Total Operating Expense
- 407.59
- Operating Income
- 33.39
- Net Income Before Taxes
- 13.14
- Net Income
- 8.38
- Diluted Normalized EPS
- 0.6
- Period
- 2023-03-31
- Total Assets
- 2316.02
- Total Liabilities
- 1455.5
- Total Equity
- 860.52
- Tangible Book Valueper Share Common Eq
- 47.49
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 251.59
- Cashfrom Investing Activities
- -133.03
- Cashfrom Financing Activities
- -140.07
- Net Changein Cash
- -21.51
- Period
- 2022-12-31
- Total Revenue
- 423.91
- Selling/ General/ Admin Expenses Total
- 69.22
- Depreciation/ Amortization
- 40.77
- Other Operating Expenses Total
- 84.08
- Total Operating Expense
- 389.94
- Operating Income
- 33.97
- Net Income Before Taxes
- 11.3
- Net Income
- 7.54
- Diluted Normalized EPS
- 0.54
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Healthcare Global Enterprises Technical
Moving Average
SMA
- 5 Day467.23
- 10 Day467.58
- 20 Day455.63
- 50 Day437.61
- 100 Day403.29
- 300 Day382.93
Healthcare Global Enterprises Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Vijaya Diagnostic Centre
- 1204.3
- 56.75
- 4.95
- 1250
- 580.75
- 12325.49
- Metropolis Healthcare
- 2056.7
- 40.5
- 2.01
- 2306.85
- 1450.05
- 10536.23
- Healthcare Global Enterprises
- 467.35
- -1.05
- -0.22
- 506.6
- 310.1
- 6509.7
- Kovai Medical Centre and Hospital
- 5233.35
- -40
- -0.76
- 5770
- 3050
- 5726.47
- Thyrocare Technologies
- 960
- -10.35
- -1.07
- 1002
- 535.05
- 5081.28
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Vijaya Diagnostic Centre
- 92.15
- 16.64
- 22.14
- 21.2
- Metropolis Healthcare
- 81.25
- 9.44
- 20.59
- 14.66
- Healthcare Global Enterprises
- 143.37
- 7.89
- -4.88
- -3.5
- Kovai Medical Centre and Hospital
- 32.44
- 6.57
- 19.28
- 12.23
- Thyrocare Technologies
- 71.49
- 9.68
- 21.96
- 19.56
Healthcare Global Enterprises Shareholding
Shareholding Pattern
*Promoter pledging: 2.2%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 09-Nov-24
- Quarterly Results
- 08-Aug-24
- Quarterly Results
- 29-May-24
- Audited Results & ESOP
- 08-Feb-24
- Quarterly Results
- 09-Nov-23
- Quarterly Results
- 10-Aug-23
- Quarterly Results & ESOP
- 25-May-23
- Audited Results
- 09-Feb-23
- Quarterly Results
- 10-Nov-22
- Quarterly Results
- 10-Aug-22
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 10-Sept-24
- 12-Aug-24
- POM
- 30-Jan-24
- 29-Dec-23
- POM
- 20-Sept-23
- 10-Aug-23
- AGM
- 27-Jun-23
- 29-May-23
- POM
- 08-May-22
- 06-Apr-22
- POM
- 25-May-21
- 26-Apr-21
- POM